UA81903C2 - Композиция смеси для грудных детей, которая содержит повышенное количество альфа-лактальбумина - Google Patents

Композиция смеси для грудных детей, которая содержит повышенное количество альфа-лактальбумина Download PDF

Info

Publication number
UA81903C2
UA81903C2 UA20040705922A UA20040705922A UA81903C2 UA 81903 C2 UA81903 C2 UA 81903C2 UA 20040705922 A UA20040705922 A UA 20040705922A UA 20040705922 A UA20040705922 A UA 20040705922A UA 81903 C2 UA81903 C2 UA 81903C2
Authority
UA
Ukraine
Prior art keywords
protein
milk
content
alpha
cow
Prior art date
Application number
UA20040705922A
Other languages
English (en)
Ukrainian (uk)
Inventor
Чарльз Френсиз Кульман
Эрик Луис Лайен
Джон Райли Вебер
Дениел Мартин О'Каллахан
Original Assignee
Уайт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23345331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA81903(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Уайт filed Critical Уайт
Publication of UA81903C2 publication Critical patent/UA81903C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение касается композиции смеси для грудных детей, содержащей количество коровьего молока, которое обеспечивает 1,0-1,2 грамма белка на 100 доступных килокалорий, и количество материала сыворотки коровьего молока, которое обеспечивает 1,0-1,2 грамма белка на 100 доступных килокалорий, причем указанный материал сыворотки коровьего молока имеет содержание альфа-лактальбумина от 28 % до 40 % и содержание бета-лактоглобулина от 8 % до 33 % общего белка.
UA20040705922A 2001-12-21 2002-12-18 Композиция смеси для грудных детей, которая содержит повышенное количество альфа-лактальбумина UA81903C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34325301P 2001-12-21 2001-12-21
PCT/US2002/040811 WO2003055322A1 (en) 2001-12-21 2002-12-18 Infant formula compositions comprising increased amounts of alpha-lactalbumin

Publications (1)

Publication Number Publication Date
UA81903C2 true UA81903C2 (ru) 2008-02-25

Family

ID=23345331

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20040705922A UA81903C2 (ru) 2001-12-21 2002-12-18 Композиция смеси для грудных детей, которая содержит повышенное количество альфа-лактальбумина

Country Status (28)

Country Link
US (1) US6913778B2 (ru)
EP (1) EP1455585B1 (ru)
JP (1) JP4317455B2 (ru)
KR (1) KR100955408B1 (ru)
CN (2) CN101427802B (ru)
AR (1) AR037909A1 (ru)
AT (1) ATE439044T1 (ru)
AU (1) AU2002357354B2 (ru)
BR (1) BR0215198A (ru)
CA (1) CA2471423C (ru)
CO (1) CO5590862A2 (ru)
CY (1) CY1109503T1 (ru)
DE (1) DE60233346D1 (ru)
DK (1) DK1455585T3 (ru)
EA (1) EA007148B1 (ru)
EC (1) ECSP045154A (ru)
ES (1) ES2329667T3 (ru)
IL (2) IL162244A0 (ru)
MX (1) MXPA04005887A (ru)
NO (1) NO20043108L (ru)
NZ (1) NZ534041A (ru)
PL (1) PL371379A1 (ru)
PT (1) PT1455585E (ru)
SG (1) SG169897A1 (ru)
TW (1) TWI301052B (ru)
UA (1) UA81903C2 (ru)
WO (1) WO2003055322A1 (ru)
ZA (1) ZA200405777B (ru)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7651716B2 (en) * 2001-12-21 2010-01-26 Wyeth Llc Methods for reducing adverse effects of feeding formula to infants
CN1310601C (zh) * 2002-10-10 2007-04-18 惠氏公司 含核苷酸的婴儿配方
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20080089981A1 (en) † 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
JP5322405B2 (ja) * 2007-06-07 2013-10-23 小林製薬株式会社 タンパク質含有組成物
US8586122B2 (en) * 2007-07-26 2013-11-19 Loders Croklaan Usa Llc Composition suitable for use in baking
EP2205240A1 (en) * 2007-10-02 2010-07-14 Ariel-University Research And Development Company, Ltd. Endocannabinoids for enhancing growth and development in infants
US8986773B2 (en) * 2008-04-29 2015-03-24 Dsm Ip Assets B.V. Process for the preparation of packaged heat-preserved aqueous drink comprising casein micelles and tryptophan-rich peptides, and product so obtained
JP5493195B2 (ja) 2008-04-29 2014-05-14 ディーエスエム アイピー アセッツ ビー．ブイ． 炭水化物およびトリプトファン含有ペプチドを含む組成物
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
WO2011051557A1 (en) * 2009-10-28 2011-05-05 Valio Ltd Whey protein product and a method for its preparation
CN101831415B (zh) * 2010-05-12 2012-05-30 江苏博立生物制品有限公司 一种提高糖化酶发酵水平的方法
WO2012077076A1 (en) * 2010-12-08 2012-06-14 Holt Patrick G Treating or preventing sensitivity to milk allergens
WO2012091542A1 (en) * 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
EP2658397A1 (en) * 2010-12-30 2013-11-06 Abbott Laboratories Improved tolerance in a low calorie infant formula
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
EP2792252B1 (en) 2011-02-10 2018-09-12 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
FI123267B (fi) * 2011-02-18 2013-01-15 Valio Oy Juusto ja sen valmistus
WO2012147075A1 (en) * 2011-04-28 2012-11-01 Shemen Industries Ltd Vegetable based oil preparation for baked goods
MX389785B (es) 2011-07-26 2025-03-18 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
EP2800480A2 (en) * 2011-11-10 2014-11-12 Nestec S.A. Infant formula with high sn-2 palmitate and oligofructose
FI125332B (fi) * 2011-11-11 2015-08-31 Valio Oy Menetelmä maitotuotteen valmistamiseksi
CN102630803A (zh) * 2012-05-15 2012-08-15 东北农业大学 母乳化牛乳蛋白及其制备方法
MX2012010488A (es) * 2012-09-11 2014-03-26 Nucitec Sa De Cv Formula infantil para el optimo crecimiento, proteccion gastrointestinal y proteccion inmunologica de infantes.
MX2012010487A (es) * 2012-09-11 2014-03-26 Nucitec Sa De Cv Composicion de nutrimientos y sustancias bioactivas que favorecen el crecimiento y que disminuyen la intolerancia y los efectos adversos en infantes prematuros.
CN103027116A (zh) * 2012-12-04 2013-04-10 内蒙古伊利实业集团股份有限公司 一种有助于睡眠的奶粉及其制备方法
WO2015154262A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them.
EP3145334B1 (en) * 2014-05-19 2019-11-13 N.V. Nutricia Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
EP3145333B1 (en) 2014-05-19 2020-11-04 N.V. Nutricia Infant formula with optimised amino acid profiles
CN104012657B (zh) * 2014-05-21 2016-04-13 澳优乳业（中国）有限公司 一种氨基酸母乳化婴幼儿配方奶粉及其制备方法
CN104522175A (zh) * 2014-12-29 2015-04-22 光明乳业股份有限公司 一种低敏婴儿配方奶粉的制备及检测方法
EP3355722A4 (en) * 2015-09-28 2019-03-13 Nestec S.A. GENDER SYNTHETIC NUTRITIONAL COMPOSITIONS AND NUTRITIONAL SYSTEMS THEREWITH
US10039805B1 (en) * 2016-02-26 2018-08-07 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US10617700B1 (en) * 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US10039765B1 (en) * 2016-02-26 2018-08-07 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US11122833B1 (en) * 2016-02-26 2021-09-21 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
EP3338841A1 (en) * 2016-12-23 2018-06-27 Ferdinand Haschke Liquid human milk supplement
CN110545679A (zh) * 2017-05-03 2019-12-06 雀巢产品有限公司 乳清蛋白质提取物及其作为鞘磷脂源的用途
JP7453915B2 (ja) * 2017-11-13 2024-03-21 キャンサー・リサーチ・テクノロジー・リミテッド 栄養製品
US11197917B2 (en) * 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
EP3897214A1 (en) * 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. Nutritional composition for inducing a feeling of satiety, a better sleep and/or limiting nocturnal awaking in infants or young children
MY208123A (en) 2019-09-16 2025-04-17 Socit Des Produits Nestl S A Whey-based nutritional compositions fortified with calcium
KR102536585B1 (ko) * 2020-08-04 2023-05-24 주식회사 엘지생활건강 액상 조제유 조성물
WO2022177965A1 (en) * 2021-02-16 2022-08-25 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
CN114568705B (zh) * 2022-03-22 2023-04-25 中国农业大学 一种有利于锌吸收的蛋白口服液及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
CA1243887A (en) 1984-07-03 1988-11-01 Shuryo Nakai REDUCING .beta.-LACTOGLOBULIN CONTENT IN WHEY PROTEIN CONCENTRATES FOR INFANT FORMULA USE
AU616411B2 (en) 1987-05-14 1991-10-31 Commonwealth Scientific And Industrial Research Organisation Whey protein fractions
GB8723651D0 (en) 1987-10-08 1987-11-11 Express Foods Group Ltd Process for containing concentrates
US5436020A (en) 1990-02-19 1995-07-25 Meiji Milk Products Company Limited Method for producing a formulated milk for infants analogous to human milk
US5169666A (en) 1991-11-14 1992-12-08 The United States Of America As Represented By The Secretary Of Agriculture Preparation of simulated human milk protein by low temperature microfiltration
JP2622789B2 (ja) 1992-02-18 1997-06-18 雪印乳業株式会社 ホエーからα−ラクトアルブミン含有量の高い画分を製造する方法及び該画分を含有せしめてなる母乳代替物または栄養組成物
EP0604684B1 (en) 1992-12-23 1997-06-11 Campina Melkunie B.V. Process for the recovery of alpha-lactalbumin and beta-lactoglobulin from a whey protein product
US6312755B1 (en) * 1999-07-16 2001-11-06 Ampc Whey treatment process for achieving high concentration of α-lactalbumin
WO2002028194A1 (en) 2000-10-05 2002-04-11 New Zealand Dairy Board Process for recovering proteins from whey protein containing feedstocks

Also Published As

Publication number Publication date
EP1455585A1 (en) 2004-09-15
US6913778B2 (en) 2005-07-05
AU2002357354A1 (en) 2003-07-15
HK1065925A1 (en) 2005-03-11
DE60233346D1 (de) 2009-09-24
CA2471423C (en) 2012-02-21
CO5590862A2 (es) 2005-12-30
TW200305371A (en) 2003-11-01
JP4317455B2 (ja) 2009-08-19
CN100456936C (zh) 2009-02-04
CN101427802A (zh) 2009-05-13
EA007148B1 (ru) 2006-08-25
ECSP045154A (es) 2004-07-23
DK1455585T3 (da) 2009-12-07
AR037909A1 (es) 2004-12-22
WO2003055322A1 (en) 2003-07-10
PT1455585E (pt) 2009-10-26
IL162244A0 (en) 2005-11-20
EA200400849A1 (ru) 2004-10-28
ES2329667T3 (es) 2009-11-30
TWI301052B (en) 2008-09-21
PL371379A1 (en) 2005-06-13
ZA200405777B (en) 2007-12-27
KR100955408B1 (ko) 2010-05-06
CN101427802B (zh) 2012-08-01
NZ534041A (en) 2005-09-30
NO20043108L (no) 2004-09-06
IL162244A (en) 2010-02-17
CY1109503T1 (el) 2012-05-23
KR20040078650A (ko) 2004-09-10
CA2471423A1 (en) 2003-07-10
ATE439044T1 (de) 2009-08-15
SG169897A1 (en) 2011-04-29
MXPA04005887A (es) 2004-09-13
US20030124237A1 (en) 2003-07-03
JP2005514017A (ja) 2005-05-19
CN1646025A (zh) 2005-07-27
BR0215198A (pt) 2004-11-16
EP1455585B1 (en) 2009-08-12
AU2002357354B2 (en) 2008-11-20

Similar Documents

Publication Publication Date Title
ES2329667T3 (es) Composiciones de formula para lactantes que comprenden cantidades aumentadas de alfalactalbumina.
US20230248043A1 (en) Nutritional composition
US7951410B2 (en) Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US9889162B2 (en) Prophylactic use for prevention of infections
US7651716B2 (en) Methods for reducing adverse effects of feeding formula to infants
US12550914B2 (en) Whey-based nutritional compositions fortified with calcium
ES2994428T3 (en) Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract
HK1065925B (en) Infant formula compositions comprising increased amounts of alpha-lactalbumin
HK40081708A (en) Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract
HK40081708B (en) Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract
HK40060822B (en) Nutritional compositions showing phase separation under gastric conditions and methods for preparing the same